Abstract
Diabetic retinopathy is the most common type of specific complication of diabetes and is the leading cause of blindness in adults. Compared with normal people, the inflammatory bacteria in the intestinal tract of diabetic retinopathy patients decreased, while the pro-inflammatory bacteria increased, leading to the increase of inflammatory factors in the body, leading to the aggravation of the condition of diabetic retinopathy patients. This provides a new research direction for the treatment of diabetic retinopathy by changing the structure and quantity of human intestinal microflora. In this review, we will summarize the research progress of intestinal microbiota and diabetic retinopathy, and discuss the action mechanism, treatment prospects and prospects of intestinal microbiota in diabetic retinopathy, so as to contribute to the development of new and targeted treatment methods in this field.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
